Not all of the Terumo products shown on this website are registered in, approved for sale in, or available for purchase in, all countries or regions where this website is accessible.
Please consult with your local Terumo representative, distribution company or customer service center for additional information.
Specific indications for use may also vary by country and region.
Product images are provided for reference only.
Blood Management Company
We are a global leader in blood component and cellular technologies.
We offer a unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing.
* Products not available in all geographies.
Blood Correction (Blood Donation Room)
Whole Blood Collection
Blood is safely collected and stored with our whole blood component processing system.
• Blood bag system with leukocyte reduction filter
Apheresis Blood Collection
Apheresis enables safe, efficient collection of specific blood components.
• Automated blood collection system
Processing (Blood Center)
Whole Blood Processing
Whole Blood Automation efficiently creates consistent, high-quality blood component products.
• Automated blood component processing system
Pathogen Reduction Technology
By greatly reducing pathogens and inactivating residual leukocytes, this technology improves the overall safety of blood transfusions.
• Pathogen reduction technology system
Transfusion (Medical Devices (To patients))
Therapeutic Apheresis and Cell Collections
Hospitals and Therapeutic Apheresis Centers
In therapeutic apheresis procedures, blood components causing disease are removed from a patient and replaced with appropriate fluids or blood components from healthy donors. Cell Collections remove specific types of cells from a patient or healthy donor to be used for targeted therapy such as a stem cell transplant or immunotherapy.
- • Centrifugal apheresis system
Cell Therapies and Point-of-Care Solutions
We support researchers and clinicians in developing cell therapies and point-of-care solutions to improve patient outcomes. This field has the potential to fundamentally change medicine.
- • Cell expansion system
- • Autologous cell processing device